Free Trial

Shattuck Labs (STTK) Stock Forecast & Price Target

Shattuck Labs logo
$1.08 +0.07 (+6.93%)
(As of 05:30 PM ET)

Shattuck Labs - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
4
Buy
1

Based on 5 Wall Street analysts who have issued ratings for Shattuck Labs in the last 12 months, the stock has a consensus rating of "Hold." Out of the 5 analysts, 4 have given a hold rating, and 1 has given a strong buy rating for STTK.

Consensus Price Target

$8.67
702.47% Upside
According to the 5 analysts' twelve-month price targets for Shattuck Labs, the average price target is $8.67. The highest price target for STTK is $16.00, while the lowest price target for STTK is $2.00. The average price target represents a forecasted upside of 702.47% from the current price of $1.08.
Get the Latest News and Ratings for STTK and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Shattuck Labs and its competitors.

Sign Up

STTK Analyst Ratings Over Time

TypeCurrent Forecast
11/27/23 to 11/26/24
1 Month Ago
10/28/23 to 10/27/24
3 Months Ago
8/29/23 to 8/28/24
1 Year Ago
11/27/22 to 11/27/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$8.67$8.67$10.67$16.33
Forecasted Upside702.47% Upside561.58% Upside212.81% Upside610.14% Upside
Consensus Rating
Hold
Hold
Moderate Buy
Buy

STTK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

STTK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Shattuck Labs Stock vs. The Competition

TypeShattuck LabsMedical CompaniesS&P 500
Consensus Rating Score
2.40
2.80
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside717.61% Upside17,731.26% Upside6.42% Upside
News Sentiment Rating
Neutral News

See Recent STTK News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/15/2024HC Wainwright
2 of 5 stars
J. Pantginis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral
11/14/2024Needham & Company LLC
3 of 5 stars
G. Blum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
10/2/2024Evercore ISI
2 of 5 stars
U. Raffat
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
10/2/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Y. Nochomovitz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$8.00 ➝ $2.00+4.17%
6/17/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Pohlman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 06:33 PM ET.


STTK Forecast - Frequently Asked Questions

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Shattuck Labs is $8.67, with a high forecast of $16.00 and a low forecast of $2.00.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shattuck Labs in the last twelve months. There are currently 4 hold ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" STTK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in STTK, but not buy additional shares or sell existing shares.

According to analysts, Shattuck Labs's stock has a predicted upside of 702.47% based on their 12-month stock forecasts.

Over the previous 90 days, Shattuck Labs's stock had 3 downgrades and 1 upgrade by analysts.

Shattuck Labs has been rated by research analysts at Citigroup, Evercore ISI, HC Wainwright, and Needham & Company LLC in the past 90 days.

Analysts like Shattuck Labs less than other "medical" companies. The consensus rating for Shattuck Labs is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how STTK compares to other companies.


This page (NASDAQ:STTK) was last updated on 11/26/2024 by MarketBeat.com Staff
From Our Partners